Investor support spurs progress at Stamford biotechs

Investor support spurs progress at Stamford biotechs


Loxo Oncology CEO Joshua Bilenker, center, and Chief Business Officer Jacob Van Naarden pose for a photo inside Loxo's Tresser Boulevard offices, in downtown Stamford, on Tuesday, July 18, 2017. Loxo Oncology CEO Joshua Bilenker, center, and Chief Business Officer Jacob Van Naarden pose for a photo inside Loxo's Tresser Boulevard offices, in downtown Stamford, on Tuesday, July 18, 2017.



from Biotech News